­
­
­
­

Inventi Impact: Biosimilars & Biopharmaceuticals

Articles

  • Inventi:pbs/31373/20
    Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
    Research 2020 : April - June
    Pradeep Kumar Mada, Matthew E Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J Alam, Mark Feldman, John William King

    Aim. To assess the effect of treating chronic hepatitis C virus (HCV) infection with direct acting antiviral drugs (DAAs) on glycemic\ncontrol in patients with concomitant diabetes mellitus (DM). Methods. We performed a retrospective case-control study in a viral\nhepatitis ambulatory clinic in Shreveport, Louisiana, during the period 11/01/2014 to 12/31/2017. All the clinic patient ages 18 years\nand above with treatment-naïve/biopsy-proven chronic hepatitis C and DM����.

    How to Cite this Article
    Attribution/ CC Compliant Citation: Mada, Pradeep Kumar, et al.\n\"Impact of Treatment with Direct Acting Antiviral Drugs on\nGlycemic Control in Patients with Hepatitis C and Diabetes\nMellitus.\" International Journal of Hepatology 2020 (2020).\nhttps://doi.org/10.1155/2020/6438753\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and\npagination were modified while adapting this article.
    Download Full Text